Document is current
Any future updates will be listed below
-
Authors
Tong, Yingying
Sun, Jie
Jiang, Xin
Jia, Xu
Jia, Yu
Wang, Hua
Wu, Jiamin
Li, Zhuocheng
Sun, Hui
Yang, Guanghua
- License Information
-
More Information
Article History
Received: 21 May 2025
Accepted: 9 October 2025
First Online: 5 November 2025
Declarations
:
: Shanghai Telebio Biomedical Technology Co., Ltd., the source of the human cells used in this study, has confirmed that initial ethical approval was obtained for their collection and that informed consent was provided by all donors. The experimental animals used in this study were approved by the Animal Ethics Committee of Shanghai Institute of Pharmaceutical Industry Co., Ltd. The project titled “Compound Treatment of Bleomycin-Induced Pulmonary Fibrosis in Rats” with approval number A-2023-06-02 was granted on August 7, 2023.
: We support inclusive, diverse, and equitable conduct of research.
: The authors declare no competing interests.
